科研日报 2026-10-12
Page content
📅 Daily Report - 2026-10-12
今日筛选出 1 条内容,来自 1 个来源
🤖 今日AI智能总结
🧪 博客更新
今日焦点: 免疫疗法在II/III期结直肠癌患者中展现出持久的术前辅助疗效,部分患者肿瘤完全消融并长期维持。
主要方向:
- 探索免疫疗法作为早期结直肠癌(II/III期)的术前辅助治疗方案。
- 评估该疗法对特定基因突变患者的长期疗效和复发预防能力。
技术亮点:
- NEOPRISM-CRC试验首次展示了短期免疫疗法对部分结直肠癌患者的“熔化”效应及持久的无病生存。
📚 分类浏览
🧪 博客更新 (1条)
详细内容(全部1条)
1. 免疫疗法后,肠癌“消失”了,并且没有复发。
- ✍️ 作者:未知作者
- 🏷️ 关键词:cancer、regex:immuno(logy|therapy|suppression)
- 📝 描述:A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer. In the NEOPRISM-CRC trial, 32 patients with a specific genetic form of bowel cancer received pembrolizumab for up to nine weeks before surgery instead of the usual post-surgery chemotherapy. After nearly three years of follow-up, none of the patients had experienced a cancer recurrence, including those who still had small traces of disease after treatment.
- 🔗 查看原文
📊 关键词统计
| 关键词 | 出现次数 |
|---|---|
| cancer | 1 |
| regex:immuno(logy | therapy |
📅 报告生成时间:2026-10-12 00:38
🤖 由 GitHub Actions 自动生成